NCT06467825View on ClinicalTrials.gov

Effect of Sex on Orthostatic Intolerance and Cardiovascular Response During Lunar Descent and Ascent

NARecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Healthy
Interventions
DRUG

Potassium Supplement

Participants will be given a potassium supplement that will help prevent low blood potassium levels.

DRUG

Furosemide 20 MG

Furosemide (Lasix, 20 mg) will be administered through IV catheter to induce urination. The goal of this procedure is to reduce the volume of plasma in the blood.

DEVICE

Compression Garment

From the torso and leg measurements obtained during Visit 1A, a custom-designed compression garment will be constructed.

Trial Locations (1)

77058

RECRUITING

NASA, Houston

All Listed Sponsors
lead

National Aeronautics and Space Administration (NASA)

FED